Deals
CD&R and McKesson Agree to Buy Option Care Health for $32.05 a Share
The home-infusion provider would go private at an enterprise value of about $5.8 billion, with McKesson taking a roughly 49% minority position alongside the private equity firm.
AF
By Anna Ferreira
Oct 6, 2026 · 2 min read
Clayton, Dubilier & Rice and McKesson have signed an agreement to acquire Option Care Health, the home and alternate-site infusion provider, for $32.05 a share in cash, according to a release Option Care Health furnished to the Securities and Exchange Commission on Form 8-K.
Discussion (0)
Sign in to join the discussion.
Loading comments…
AF
Anna Ferreira
Senior Correspondent, Corporate Strategy
Anna Ferreira writes for Corporate Insider Inc.